Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02743845 · ClinicalTrials.gov registry record

Gene Discovery Core, The Manton Center

A clinical trial of Rare Disorders and Undiagnosed Conditions, sponsored by Boston Children's Hospital.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT02743845: Recruiting study of Rare Disorders and Undiagnosed Conditions, sponsored by Boston Children's Hospital.

NCT02743845 is a study of Rare Disorders and Undiagnosed Conditions that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02743845, a study of Rare Disorders and Undiagnosed Conditions, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

The Gene Discovery Core at The Manton Center for Orphan Disease Research based at Boston Children's Hospital studies families with rare, poorly understood or undiagnosed, but suspected genetic conditions. The primary goal of the research is to better understand the genes and proteins (gene products) involved in rare diseases. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with rare disease in the future. Individuals with any rare/undiagnosed condition are eligible to enroll. Enrollment includes: * Providing DNA and tissue samples (when available) * Access to participants' medical records * Access to genomic data (when available) Samples are used for genetic analysis (primarily exome and genome sequencing or reanalysis) to identify the genetic cause for the individual's illness. Individual research results are returned to families through their health care provider after confirmation in a clinical lab. If a cause is identified, that can be reported back to the family through their health care provider and the study's genetic counselor. When possible, the investigators also collect samples from parents and full-siblings as well as any other affected family members.

Primary Outcome

Functional analysis, including animal modeling and cell line assays, will be performed for novel candidate genes. When a molecular diagnosis is identified for a family, this is reported back through a designated health care provider.

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2010-02
Est. Completion 2030-12
Boston Children's Hospital

462 total trials

What NCT02743845 shows while recruiting

NCT02743845 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 3 conditions, with Rare Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT02743845 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02743845 about?

NCT02743845 is a clinical study titled "Gene Discovery Core, The Manton Center". The Gene Discovery Core at The Manton Center for Orphan Disease Research based at Boston Children's Hospital studies families with rare, poorly understood or undiagnosed, but suspected genetic conditions. The primary goal of the research is to better understand the genes and proteins (gene products)...

What is the current status of trial NCT02743845?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2010-02. Estimated completion is 2030-12.

What conditions does trial NCT02743845 study?

This clinical trial studies the following conditions: Rare Disorders, Undiagnosed Conditions, Orphan Diseases.

Who is sponsoring clinical trial NCT02743845?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02743845 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rare Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02743845, the US trial registry maintained by the National Library of Medicine. NCT02743845 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.